Literature DB >> 19252296

Increased plasma dipeptidyl peptidase IV (DPP IV) activity and decreased DPP IV activity of visceral but not subcutaneous adipose tissue in impaired glucose tolerance rats induced by high-fat or high-sucrose diet.

Yasushi Kirino1, Takayuki Kamimoto, Youichi Sato, Kazuyoshi Kawazoe, Kazuo Minakuchi, Yutaka Nakahori.   

Abstract

Several studies have investigated whether dipeptidyl peptidase IV (DPP IV) activity is correlated to the severity of diabetes; however, it remains unclear. To investigate the roles of DPP IV activity in metabolic abnormalities, impaired glucose tolerance rats were produced using a high-fat (HF) or high-sucrose (HS) diet. HF diet-fed rats obviously exhibited impaired glucose tolerance, with increases in subcutaneous and epididymal fat mass, insulin resistance and dyslipidaemia. In rats fed a HS diet rather than a normal diet, lower body weight and fasting blood glucose were observed temporarily in the early period after HS diet feeding; however, impaired glucose tolerance was evoked to some extent with an increase in epididymal fat mass. Both HF and HS diet-fed rats showed significantly higher plasma DPP IV activity than normal diet-fed rats, in the order of HF diet>HS diet>normal diet. HF and HS diets did not significantly affect DPP IV activity and mRNA expression in the kidney. On the other hand, HF, but not HS, diet caused a significant decrease in DPP IV activity in the liver as compared to the control. Of note, both HF and HS diets caused a significant decrease in DPP IV activity in epididymal fat, even though they did not change DPP IV activity in subcutaneous fat. In conclusion, HF or HS diet-induced impaired glucose tolerance with visceral fat accumulation may be interrelated with increased plasma DPP IV activity and decreased DPP IV activity of visceral but not subcutaneous adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252296     DOI: 10.1248/bpb.32.463

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

Review 1.  Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system.

Authors:  Annayya R Aroor; James R Sowers; Guanghong Jia; Vincent G DeMarco
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

2.  Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.

Authors:  Ravi Nistala; Javad Habibi; Guido Lastra; Camila Manrique; Annayya R Aroor; Melvin R Hayden; Mona Garro; Alex Meuth; Megan Johnson; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinology       Date:  2014-04-08       Impact factor: 4.736

3.  Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats.

Authors:  Kim A Pyra; Dolan C Saha; Raylene A Reimer
Journal:  J Nutr       Date:  2012-01-05       Impact factor: 4.798

4.  Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats.

Authors:  Raylene A Reimer; Gary J Grover; Lee Koetzner; Roland J Gahler; Prateek Juneja; Michael R Lyon; Simon Wood
Journal:  J Nutr       Date:  2012-08-22       Impact factor: 4.798

5.  Variation in gene expression of presenilins-associated rhomboid-like protein and mitochondrial function in skeletal muscle of insulin-resistant rats.

Authors:  Huiqin Tang; Jie Liu; Li Niu; Wenbo He; Yancheng Xu
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

6.  [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb/db type 2 diabetic mice.

Authors:  Mehdi Bin Samad; Md Nurul Absar Bin Mohsin; Bodiul Alam Razu; Mohammad Tashnim Hossain; Sinayat Mahzabeen; Naziat Unnoor; Ishrat Aklima Muna; Farjana Akhter; Ashraf Ul Kabir; J M A Hannan
Journal:  BMC Complement Altern Med       Date:  2017-08-09       Impact factor: 3.659

7.  Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.

Authors:  Yu-Na Chae; Tae-Hyoung Kim; Mi-Kyung Kim; Chang-Yell Shin; Il-Hoon Jung; Yong Sung Sohn; Moon-Ho Son
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.